<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0"><channel><title>Individual feed for http://feeds.benzinga.com/benzinga</title><link>http://feeds.benzinga.com/benzinga</link><description>Individual feed output.</description><lastBuildDate>Fri, 24 Oct 2025 11:12:36 GMT</lastBuildDate><generator>PyRSS2Gen-1.1.0</generator><docs>http://blogs.law.harvard.edu/tech/rss</docs><item><title>America's Leading  Hospital Operator HCA Healthcare Outperforms Citing Solid Patient Volumes</title><link>https://www.benzinga.com/markets/earnings/25/10/48406203/americas-leading-hospital-operator-hca-healthcare-outperforms-citing-solid-patient-volumes</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/24/Pearland--Texas--Usa---February-19--2022.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>HCA Healthcare beats Q3 estimates with 9.6% revenue growth and higher earnings, raising its 2025 guidance on strong patient volume and stable conditio...</description><pubDate>Fri, 24 Oct 2025 15:23:16 GMT</pubDate></item><item><title>FDA Approves GSK's Withdrawn Blood Cancer Drug Blenrep</title><link>https://www.benzinga.com/news/fda/25/10/48406201/fda-approves-gsks-withdrawn-blood-cancer-drug-blenrep</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/24/Multiple-Myeloma.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>FDA approves GSK's Blenrep combo for relapsed multiple myeloma, showing 51% reduced death risk and tripled progression-free survival in Phase 3 trial....</description><pubDate>Fri, 24 Oct 2025 15:23:06 GMT</pubDate></item><item><title>Intel Shares Are Climbing Higher Thursday: What's Going On?</title><link>https://www.benzinga.com/trading-ideas/movers/25/10/48406019/intel-shares-are-climbing-higher-thursday-whats-going-on</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/24/Intel-Forecasts-Slight-Dip.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Intel shares are trading higher Friday after the company reported third quarter earnings per share and sales above expectations. read more</description><pubDate>Fri, 24 Oct 2025 15:19:51 GMT</pubDate></item><item><title>Here's How Much You Would Have Made Owning Popular Stock In The Last 10 Years</title><link>https://www.benzinga.com/insights/news/25/10/48405847/heres-how-much-you-would-have-made-owning-popular-stock-in-the-last-10-years</link><image_url>https://lead-mark.github.io/snippets/genNewsImagesTwo/Picture9.png</image_url><description>read more</description><pubDate>Fri, 24 Oct 2025 15:15:16 GMT</pubDate></item><item><title>What's Going On With Rocket Lab (RKLB) Stock Friday?</title><link>https://www.benzinga.com/trading-ideas/movers/25/10/48405813/whats-going-on-with-rocket-lab-rklb-stock-friday</link><image_url>https://cdn.benzinga.com/files/images/story/2025/10/24/Rocket-Lab-Building-Sign--Auckland--New-.jpeg?optimize=medium&amp;dpr=1&amp;auto=webp&amp;height=675&amp;width=1200&amp;fit=crop</image_url><description>Rocket Lab shares are trading marginally higher Friday morning as investors digest a recent, bullish analyst report and recent operational achievement...</description><pubDate>Fri, 24 Oct 2025 15:14:29 GMT</pubDate></item></channel></rss>